SCHEMBL9304860

SCHEMBL9304860

C=CCN(C=O)c1c(N)[nH]c(=O)n(CC=C)c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.38
ADORA3 P0DMS8 1/20 0.38
CYP3A4 P08684 2/20 0.33
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 2/20 0.31
HTT P42858 2/20 0.31
LMNA P02545 2/20 0.31
RECQL P46063 2/20 0.31
USP2 O75604 2/20 0.31
POLB P06746 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ADORA1 P30542 1/20 0.31
ADORA2A P29274 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2D6 P10635 2/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
CYP2C19 P33261 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5441771 0.74 ADORA2B (0.46) ADORA2BADORA3CYP3A4KDM4EALDH1A1
SCHEMBL9305429 0.70 ADORA3 (0.44) ADORA3CYP3A4KDM4EALDH1A1HTT
SCHEMBL28178756 0.70 ADORA2B (0.43) ADORA2BADORA3CYP3A4KDM4EALDH1A1
SCHEMBL157928 0.63 CYP3A4 (0.71) ADORA2BADORA3CYP3A4KDM4EALDH1A1
SCHEMBL5449552 0.62 CYP3A4 (0.50) ADORA2BADORA3CYP3A4KDM4EALDH1A1
SCHEMBL9300715 0.62 L3MBTL1 (0.32) ADORA2BADORA3KDM4EALDH1A1SMN1; SMN2
SCHEMBL11077876 0.62 CYP3A4 (0.68) ADORA2BADORA3CYP3A4KDM4EALDH1A1
SCHEMBL181982 0.62 CYP3A4 (0.54) ADORA2BADORA3CYP3A4KDM4EALDH1A1
SCHEMBL26948738 0.61 ADORA3 (0.46) ADORA2BADORA3CYP3A4KDM4EALDH1A1
SCHEMBL11591427 0.61 ADORA2B (0.57) ADORA2BADORA3CYP3A4KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0531349-A1 1-7 SUBSTITUTED XANTHINE DERIVATIVES HAVING ANTIASTHMATIC ACTIVITY, THEIR SALTS PHYSIOLOGICALLY ACCEPTABLE, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THEIR PREPARATION MALESCI ISTITUTO FARMACOBIOLOGICO S.p.A. (IT) 1993-03-17 EP claimed
WO-1991017993-A1 1-7 SUBSTITUTED XANTHINE DERIVATIVES HAVING ANTIASTHMATIC ACTIVITY, THEIR SALTS PHYSIOLOGICALLY ACCEPTABLE, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THEIR PREPARATION MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A (IT) 1991-11-28 WO claimed
US-5314890-A Treatment of asthma MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A. (IT) 1994-05-24 US disclosed
EP-0531349-A1 1-7 SUBSTITUTED XANTHINE DERIVATIVES HAVING ANTIASTHMATIC ACTIVITY, THEIR SALTS PHYSIOLOGICALLY ACCEPTABLE, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THEIR PREPARATION MALESCI ISTITUTO FARMACOBIOLOGICO S.p.A. (IT) 1993-03-17 EP disclosed
WO-1991017993-A1 1-7 SUBSTITUTED XANTHINE DERIVATIVES HAVING ANTIASTHMATIC ACTIVITY, THEIR SALTS PHYSIOLOGICALLY ACCEPTABLE, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THEIR PREPARATION MALESCI ISTITUTO FARMACOBIOLOGICO S.P.A (IT) 1991-11-28 WO disclosed